Clinical trial
Effect of Denileukin Diftitox on Immune System in CTCL Patients
NCT00254332 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00254332 |
|---|---|
| Title | Effect of Denileukin Diftitox on Immune System in CTCL Patients |
| Official title | Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides |
| Enrollment | 10 |
| Start date | Nov 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Nov 16, 2005 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: